You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
永勝醫療(01612.HK)中期溢利3360萬港元 同比增加23.9%
格隆匯 08-21 16:37

格隆匯8月21日丨永勝醫療(01612.HK)公吿,集團於截至2024年6月30日止6個月達至穩定增長,收入同比增加5.4%至3.8億港元。期間溢利達3360萬港元,同比增加23.9%。每股基本盈利為5.17港仙(2023年上半年:4.10港仙)。董事會議決於2024年9月27日(星期五)或前後派付本期間中期股息每股1.6港仙(2023年上半年:1.25港仙)。

成像一次性產品分部的強勁增長,足以完全抵銷有餘呼吸產品分部及骨科支護康復器具分部收入減少的影響。集團意識到研究與開發及產品創新為長遠增長主要推動力,並繼續致力投放資源於研發。於中華人民共和國廣東省江門市開平市的新研發生產設施("新生產設施")建設進度良好,目標於2025年年底試行運作。 

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account